Loading…
Lobbying Spend
—
Filings
63
Firms Hired
3
Active Period
2004–2019
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
National Defense Authorization Act for Fiscal Year 2018
2017 · fourth_quarter · Firm: NVG, LLC
H.R. 2810, National Defense Authorization Act for FY 2018; March in Rights under the Bayh-Dole Act; intellectual property.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2810
Combination Drug Development Incentive Act of 2013
2014 · fourth_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
Vaccine related issues and general biological issues, including biodefense and H.R. 2985, the Combination Drug Development Act of 2013.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2014 · third_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
Vaccine related issues and general biological issues, including biodefense and H.R. 2985, the Combination Drug Development Incentive Act of 2013.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2014 · second_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
Vaccine related issues and general biological issues, including biodefense and H.R. 2985, the Combination Drug Development Incentive Act of 2013.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2985
Combination Drug Development Incentive Act of 2013
2014 · first_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
Vaccine related issues and general biological issues, including H.R. 2985, the Combination Drug Development Incentive Act of 2013.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2985
School Access to Emergency Epinephrine Act
2012 · third_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
Vaccine related issues and general biological issues generally, as well as the Independent Payment Advisory Board (IPAB), dengue fever, and H.R. 3627/S. 1884, School Access to Emergency Epinephrine Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3627
Global Investment in American Jobs Act of 2012
2012 · third_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
General issues related to foreign direct investment in the United States, including all provisions of S. 3274 and H.R. 5910, Global Investment in American Jobs Act of 2012.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5910
School Access to Emergency Epinephrine Act
2012 · second_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
Vaccine related issues and general biological issues generally, as well as the Prescription Drug User Fee Act (PDUFA), Independent Payment Advisory Board (IPAB), dengue fever, and H.R. 3627/S. 1884, School Access to Emergency Epinephrine Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3627
Global Investment in American Jobs Act of 2012
2012 · second_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
General issues related to foreign direct investment in the United States, including all provisions of S. 3274 and H.R.5910, Global Investment in American Jobs Act of 2012.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5910
Flu Vaccine Availability Act of 2008
2008 · second_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
Vaccine related issues. Flue Education Bill (H.R. 4251), SCHIP, Patent Reform, FISA, Follow-on Biologics, Bio Defense, Sunshine Act for Doctors
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4251
Flu Vaccine Availability Act of 2008
2008 · first_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.
Vaccine related issues. Flu Education Bill (H.R. 4251), SCHIP, Patent Reform, Foreign Intelligence Surveillance Act, Follow-on Biologics, BioDefense, Sunshine Act for Doctors
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4251
Source: Senate LDA